The highest court in the United States stopped lower courts from stopping or restricting the use of a pill called mifepristone, which the FDA has approved for abortion, for some time in the future.

 The Supreme Court didn't make a final decision on the case and left it to the 5th Circuit Court of Appeals, which will hold a hearing on May 17. No matter what the decision of the 5th Circuit Court is, the case will most likely go back to the Supreme Court, and a decision could be made next term.

 For the time being, the drug will be easily accessible, especially in states where abortion is lawful within the first 10 weeks of pregnancy, as a result of the court's decision.

 The Court of Appeals has limited the scope of the stay, which means that even if the stay is not expanded, mifepristone will not be removed from the market.

 On Friday, President Biden stated that his administration will support the FDA's approval of mifepristone, and he urged the public to vote for legislators who will enact laws to restore abortion rights.

 The most recent legal dispute over abortion started on April 7 in Texas, when U.S. District Judge Matthew Kacsmaryk, who was formerly an anti-abortion activist, enforced a nationwide prohibition on mifepristone. He declared that the FDA had authorized the drug unlawfully 23 years ago.